After signing up, you'll start to receive regular news updates from us.
UPLC Applications Ubiquitous at HPLC 2006
Complete the form below to unlock access to ALL audio articles.
Waters Corporation has announced that its Ultra Performance LC™ (UPLC™) technology takes center stage at the 30th International Symposium on High Performance Liquid Phase Separations and Related Techniques.
This year’s conference is being held from June 17-23 at the San Francisco Marriott Hotel.
Waters scientists are presenting 20 posters and papers centering on UPLC technology in poster topics as diverse as pharmaceutical analysis, proteomics, clinical, pharmaceutical separations and analysis, method development, life sciences and drug discovery, biotechnology, food safety, and metabolite ID.
Its enhanced levels of efficiency, sensitivity, and speed have caused research and industry scientists from other companies and academic institutions to make strategic investments in UPLC technology, often combining it with mass spectrometry for a system solution.
Waters UPLC, UPLC/MS systems and/or UPLC chemistries are featured in posters and presentations from 62 scientists at: Amgen, Baxter Healthcare, Bristol-Myers Squibb, Dalian Institute of Chemical Physics (P.R. China), Dow Chemical Co., Hospital Universitario Reina Sofía, (Spain), Imperial College, Kings College, Merck & Co. Inc., Pacific Northwest National Laboratory, Pfizer Global Research and Development, Tufts University, Unilver, University of New Mexico, U.S. Drug Enforcement Administration and Wyeth.
UPLC-Enabled Bioseparations Focus in Booth 400:
Waters is displaying two of its latest bioseparations innovations: UPLC Amino Acid and Peptide Analysis Application Solutions.
Designed to leverage the strengths that UPLC technology delivers in sensitivity, resolution and speed, both system solutions are equipped to meet the demands for high-quality analyses and come complete with chemistry, instrumentation, methodology, documentation and application support.
Featured in each solution is company’s UPLC-based detectors, the ACQUITY™ SQ Detector.
It is a benchtop, ultra-compact, single-quadrupole, atmospheric pressure ionization mass detector.
Together with an ACQUITY UPLC System and mass spectrometer, the ACQUITY SQD enables scientists to attain more information about the identity of pharmaceutical, biological, industrial and environmental compounds than conventional UV/Vis-based detector systems.
First introduced at this year’s Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, both application solutions are currently shipping.
Waters’ booth also includes a number of its premier chemistry brands: XBridge™ HPLC columns that provide LC method developers with degrees of improvement in high pH stability and higher level of performance; ACQUITY UPLC BEH™ columns that are based on efficient and rugged 1.7 µm Bridged Ethyl Hybrid (BEH) particle technology; and Atlantis® analytical columns that provide full LC/MS compatibility, peak shapes and column-to-column reproducibility.
To complement these columns, the company is also exhibiting its Oasis® family of sample preparation products.
Rounding out the exhibit are short courses by Waters senior scientists on FDA methods development and validation and developing SPE standards for sample preparation.
The company is also sponsoring two vendor seminars entitled "Introducing the New Standard for Polar Compound Retention in Reversed-Phase HPLC" on Wednesday, June 21st and "Theories, Concepts and Column Chemistries for UPLC" on Thursday, the 22nd in the Golden Gate Exhibit Hall at the hotel.
